Impact of Hormone Therapy on Mood Swings

A new real-world study finds that hormone therapy cut severe mood symptoms in midlife women by more than half, giving doctors a fresh clue about one of menopause’s most frustrating side effects.

Quick Take

  • A 2026 study found severe mood symptoms dropped from 62.3% to 24.6% in women using systemic hormone therapy.
  • The biggest gains showed up in women who started with the worst mood symptoms.
  • Decades of research show hormone therapy helps some women more than others, depending on menopause stage.
  • Doctors say mood symptoms tied closely to hormone swings respond best to treatment.

What The New Study Actually Found

Researchers tracked midlife women who started systemic hormone therapy and measured their mood using a standard psychological symptom scale. Before treatment, 62.3% of women scored in the severe mood symptom range. After treatment, that number fell to 24.6%. The drop was statistically significant, meaning it was unlikely to happen by chance.

The women who started out struggling the most saw the biggest turnaround. Researchers noted the mean improvement was steepest among those with severe baseline symptoms, suggesting hormone therapy works best for women whose mood problems are tightly linked to hormone changes rather than other causes.

This tracks with what doctors have suspected for years. When mood symptoms rise and fall alongside hot flashes, sleep trouble, and other classic menopause signs, hormone therapy tends to help more. When mood problems stem from separate issues like clinical depression unrelated to hormones, the benefit shrinks.

Decades Of Mixed Signals Finally Make Sense

This is not the first study to link hormone therapy with better mood. A 1997 meta-analysis of 26 studies found an overall effect size of 0.68, meaning the average treated woman felt less depressed than 76% of women who did not get treatment. That early data set the stage for decades of follow-up research trying to confirm and refine the finding.

Newer reviews complicate that simple picture. A 2025 analysis found hormone therapy brings only a modest reduction in depressive symptoms for perimenopausal women, with the size of the benefit small and the certainty of the evidence limited. Other researchers found little support for using estrogen to lift mood in women who were not already struggling, though some benefit appeared in women going through perimenopause specifically.

The pattern that keeps showing up across studies is timing. Estrogen supplementation, especially early in postmenopause, has been tied to modest drops in depressive symptoms, with the transdermal patch form showing the steadiest results. That lines up with a broader theory: hormone therapy works best while hormone levels are actively swinging, not after they have settled into a new normal.

Why The Treatment Combo Matters

Not every hormone regimen produces the same results. One clinical study using combined estrogen-progesterone therapy over three 28-day treatment courses found higher overall effectiveness in the treatment group compared to controls. But other research found the progesterone component in combined therapy sometimes worked against the mood benefits provided by estrogen alone.

A British retrospective cohort study offers one of the clearest real-world snapshots. After a mean follow-up of 107 days, global mood-symptom scores nearly cut in half, a 44.6% reduction, and researchers found the drop was statistically significant. All twelve individual mood symptoms tracked in the study improved after women started or adjusted their hormone therapy, whether that included estrogen alone, estrogen with progesterone, or added testosterone.

What This Means For Women Weighing Their Options

Medical guidance already points doctors toward hormone therapy specifically when mood symptoms line up with hormonal swings and low estrogen signs during perimenopause. For women meeting the criteria for full-blown depression or anxiety disorders, antidepressants remain the first-line treatment, sometimes paired with hormone therapy rather than replacing it.

The practical takeaway is not that hormone therapy fixes every mood problem tied to menopause. It is that women whose irritability, sadness, or anxiety rise and fall with their hormone levels now have real data backing up what many have long suspected. Talking with a doctor about timing, dosage form, and whether progesterone should be included matters as much as the decision to start treatment at all.

Sources:

mindbodygreen.com, pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov, psychiatryonline.org, frontiersin.org